Article citationsMore>>

J. A. Cohen, A. J. Coles, D. L. Arnold, C. Confavreux, E. J. Fox, H. P. Hartung, E. Havrdova, K. W. Selmaj, H. L. Weiner, E. Fisher, W. Brinar, G. Giovannoni, M. Stojanovic, B. I. Ertik, S. L. Lake, D. H. Margolin, M. A. Panzara and D. A. Compston, “Alemtuzumab Versus Interferon Beta 1a as First-Line Treatment For Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Controlled Phase 3 Trial,” Lancet, Vol. 380, No. 9856, 2012, pp. 1819-1828.
http://dx.doi.org/10.1016/S0140-6736(12)61769-3

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top